{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T19:01:23Z","timestamp":1780167683376,"version":"3.54.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsmedizin Rostock"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      MicroRNAs (miRNAs) play pivotal roles in glioblastoma (GBM) progression and therapy resistance. Among them, miR-25-3p has emerged as a key oncogenic miRNA that promotes tumor growth, invasiveness, and resistance to temozolomide (TMZ). In this study, we profiled miRNA expression in primary GBM specimens (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200950) stratified by\n                      <jats:italic>MGMT<\/jats:italic>\n                      methylation and\n                      <jats:italic>TP53<\/jats:italic>\n                      mutation status and assessed the functional impact of miR-25-3p inhibition in seven patient-derived GBM cell lines. Quantitative PCR analysis revealed upregulation of miR-135b in\n                      <jats:italic>MGMT<\/jats:italic>\n                      -methylated tumors and miR-10b in\n                      <jats:italic>TP53<\/jats:italic>\n                      -mutant cases. Both miR-25-3p and miR-10b were significantly elevated in 3D spheroid cultures compared to 2D monolayers. Notably, both miRNAs were secreted via tumor-derived extracellular vesicles, implicating a role in cell-cell communication. Inhibition of miR-25-3p in GBM cell lines consistently suppressed \u03b2-catenin and re-induced FBXW7 expression across all cases, correlating with inhibitor uptake. In four of seven cell lines, miR-25-3p inhibition enhanced TMZ sensitivity and reduced invasiveness, although the anti-invasive effect was not further potentiated by the addition of TMZ. In addition, RNA-Seq and methylome analyses revealed genetic and epigenetic reprograming toward a less aggressive, less invasive phenotype with reduced stemness potential. These findings highlight the interplay between tumor microenvironment and molecular heterogeneity in shaping miRNA dynamics in GBM. Collectively, our results identify miR-25-3p as a promising dual-action therapeutic target to mitigating both invasion and chemoresistance in GBM, warranting further translational investigation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>miRNA-mediated regulation of invasion, protein synthesis, and drug sensitivity in glioblastoma. Schematic overview of miRNA-mediated regulation of glioblastoma cell behavior. miRNAs modulate mRNA targets and protein synthesis, influencing \u03b2-catenin signaling, invasion capacity, and temozolomide sensitivity through FBXW7-associated pathways, ultimately affecting apoptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10571-026-01750-6","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:23:13Z","timestamp":1780165393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via \u03b2-catenin Downregulation"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9369-372X","authenticated-orcid":false,"given":"Katharina","family":"Richter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Markmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-497X","authenticated-orcid":false,"given":"Philipp","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3348-8005","authenticated-orcid":false,"given":"Annabell","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9371-2709","authenticated-orcid":false,"given":"Stefan","family":"Simm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-8429","authenticated-orcid":false,"given":"Daniel","family":"Dubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-0575","authenticated-orcid":false,"given":"Florian","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2591-2829","authenticated-orcid":false,"given":"Thomas M.","family":"Freiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2812-2440","authenticated-orcid":false,"given":"Timo","family":"Kirschstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-777X","authenticated-orcid":false,"given":"Christian","family":"Junghanss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8389-8439","authenticated-orcid":false,"given":"Claudia","family":"Maletzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0282-7330","authenticated-orcid":false,"given":"Bjoern","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"1750_CR1","doi-asserted-by":"publisher","unstructured":"Adams D et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. New Engl J Med 379(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153","DOI":"10.1056\/NEJMoa1716153"},{"key":"1750_CR2","doi-asserted-by":"publisher","unstructured":"Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350\u2013355. https:\/\/doi.org\/10.1038\/nature02871","DOI":"10.1038\/nature02871"},{"key":"1750_CR3","doi-asserted-by":"publisher","unstructured":"Bartel DP (2004) MicroRNAs. Cell 116(2):281\u2013297. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5","DOI":"10.1016\/S0092-8674(04)00045-5"},{"issue":"3","key":"1750_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2174\/157489210791760526","volume":"5","author":"R Bei","year":"2010","unstructured":"Bei R, Marzocchella L, Turriziani M (2010) The use of temozolomide for the treatment of malignant tumors: clinical evidence and molecular mechanisms of action. Recent Pat Anti-cancer Drug Discov 5(3):172\u2013187. https:\/\/doi.org\/10.2174\/157489210791760526","journal-title":"Recent Pat Anti-cancer Drug Discov"},{"key":"1750_CR5","doi-asserted-by":"publisher","unstructured":"Boicean A et al (2023) Has-miR-129-5p\u2019s involvement in different disorders, from digestive cancer to neurodegenerative diseases. Biomedicines 11(7):2058. https:\/\/doi.org\/10.3390\/biomedicines11072058","DOI":"10.3390\/biomedicines11072058"},{"issue":"2","key":"1750_CR6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW et al (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462\u2013477. https:\/\/doi.org\/10.1016\/j.cell.2013.09.034","journal-title":"Cell"},{"key":"1750_CR7","unstructured":"BWA-Mem2 (n.d.). https:\/\/github.com\/bwa-mem2\/bwa-mem2"},{"key":"1750_CR8","unstructured":"BWAmeth (n.d.). https:\/\/github.com\/brentp\/bwa-meth"},{"key":"1750_CR9","doi-asserted-by":"publisher","first-page":"138305","DOI":"10.1016\/j.neulet.2025.138305","volume":"863","author":"K Caro","year":"2025","unstructured":"Caro K et al (2025) C1ql3 promotes cognitive flexibility behavior in mice. Neurosci Lett 863:138305. https:\/\/doi.org\/10.1016\/j.neulet.2025.138305","journal-title":"Neurosci Lett"},{"issue":"9","key":"1750_CR10","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1111\/j.1349-7006.2010.01616.x","volume":"101","author":"G Chai","year":"2010","unstructured":"Chai G et al (2010) MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci 101(9):1997\u20132004. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01616.x","journal-title":"Cancer Sci"},{"issue":"1","key":"1750_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-017-0754-0","volume":"17","author":"H Chen","year":"2018","unstructured":"Chen H et al (2018) MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2. Mol Cancer 17(1):4. https:\/\/doi.org\/10.1186\/s12943-017-0754-0","journal-title":"Mol Cancer"},{"issue":"8","key":"1750_CR11","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/cas.15445","volume":"113","author":"C Chen","year":"2022","unstructured":"Chen C et al (2022) <scp>AUP1<\/scp> regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma. Cancer Sci 113(8):2600\u20132615. https:\/\/doi.org\/10.1111\/cas.15445","journal-title":"Cancer Sci"},{"issue":"5","key":"1750_CR13","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","volume":"21","author":"S Darmanis","year":"2017","unstructured":"Darmanis S et al (2017) Single-cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep 21(5):1399\u20131410. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.030","journal-title":"Cell Rep"},{"key":"1750_CR14","doi-asserted-by":"publisher","unstructured":"Davis M (2016) Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 20(5):S2\u2013S8. https:\/\/doi.org\/10.1188\/16.CJON.S1.2-8","DOI":"10.1188\/16.CJON.S1.2-8"},{"issue":"13","key":"1750_CR15","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1182\/blood-2008-12-194290","volume":"114","author":"J Dutta-Simmons","year":"2009","unstructured":"Dutta-Simmons J et al (2009) Aurora kinase A is a target of Wnt\/\u03b2-catenin involved in multiple myeloma disease progression. Blood 114(13):2699\u20132708. https:\/\/doi.org\/10.1182\/blood-2008-12-194290","journal-title":"Blood"},{"issue":"12","key":"1750_CR16","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1111\/febs.15625","volume":"288","author":"KH Ebrahimi","year":"2021","unstructured":"Ebrahimi KH et al (2021) Interferon-stimulated gene products as regulators of central carbon metabolism. FEBS J 288(12):3715\u20133726. https:\/\/doi.org\/10.1111\/febs.15625","journal-title":"FEBS J"},{"issue":"1","key":"1750_CR17","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1038\/s41467-025-59860-6","volume":"16","author":"A Engel","year":"2025","unstructured":"Engel A et al (2025) A spatio-temporal brain miRNA expression atlas identifies sex-independent age-related microglial driven miR-155-5p increase. Nat Commun 16(1):4588. https:\/\/doi.org\/10.1038\/s41467-025-59860-6","journal-title":"Nat Commun"},{"issue":"1","key":"1750_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41698-024-00653-3","volume":"8","author":"T Freitag","year":"2024","unstructured":"Freitag T et al (2024) Combined inhibition of EZH2 and CDK4\/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma. npj Precision Oncol 8(1):156. https:\/\/doi.org\/10.1038\/s41698-024-00653-3","journal-title":"npj Precision Oncol"},{"issue":"2","key":"1750_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-018-2894-5","volume":"139","author":"T Fujihara","year":"2018","unstructured":"Fujihara T et al (2018) Down-regulation of MDR1 by Ad-DKK3 via Akt\/NF\u03baB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model. J Neurooncol 139(2):323\u2013332. https:\/\/doi.org\/10.1007\/s11060-018-2894-5","journal-title":"J Neurooncol"},{"issue":"1","key":"1750_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-017-0209-7","volume":"15","author":"DM Gomez Zubieta","year":"2017","unstructured":"Gomez Zubieta DM et al (2017) MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells. Cell Commun Signal 15(1):55. https:\/\/doi.org\/10.1186\/s12964-017-0209-7","journal-title":"Cell Communication Signal"},{"issue":"14","key":"1750_CR21","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B et al (2020) miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci 16(14):2628\u20132647. https:\/\/doi.org\/10.7150\/ijbs.47203","journal-title":"Int J Biol Sci"},{"issue":"10","key":"1750_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME et al (2005) MGMT Gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"issue":"33","key":"1750_CR23","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/onc.2017.34","volume":"36","author":"P-S Hu","year":"2017","unstructured":"Hu P-S et al (2017) NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma. Oncogene 36(33):4706\u20134718. https:\/\/doi.org\/10.1038\/onc.2017.34","journal-title":"Oncogene"},{"key":"1750_CR24","doi-asserted-by":"publisher","first-page":"100078","DOI":"10.1016\/j.bbadva.2023.100078","volume":"3","author":"N Istiqamah","year":"2023","unstructured":"Istiqamah N et al (2023) Identification of key microRNAs regulating ELOVL6 and glioblastoma tumorigenesis. BBA Adv 3:100078. https:\/\/doi.org\/10.1016\/j.bbadva.2023.100078","journal-title":"BBA Adv"},{"issue":"1","key":"1750_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cell.2015.08.010","volume":"163","author":"H Jiang","year":"2015","unstructured":"Jiang H et al (2015) Phase transition of spindle-associated protein regulate spindle apparatus assembly. Cell 163(1):108\u2013122. https:\/\/doi.org\/10.1016\/j.cell.2015.08.010","journal-title":"Cell"},{"issue":"4","key":"1750_CR26","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/S10143-020-01403-2","volume":"44","author":"L Jin","year":"2020","unstructured":"Jin L et al (2020) Optimal treatment strategy for adult patients with newly diagnosed glioblastoma: a systematic review and network meta-analysis. Neurosurgical Rev 2020 44(4):1943\u20131955. https:\/\/doi.org\/10.1007\/S10143-020-01403-2","journal-title":"Neurosurgical Rev 2020"},{"issue":"6","key":"1750_CR27","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ctrv.2008.03.125","volume":"34","author":"T-CA Johannessen","year":"2008","unstructured":"Johannessen T-CA, Bjerkvig R, Tysnes BB (2008) DNA repair and cancer stem-like cells\u2014potential partners in glioma drug resistance? Cancer Treat Rev 34(6):558\u2013567. https:\/\/doi.org\/10.1016\/j.ctrv.2008.03.125","journal-title":"Cancer Treat Rev"},{"issue":"14","key":"1750_CR28","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-06-2316","volume":"13","author":"M Katoh","year":"2007","unstructured":"Katoh M, Katoh M (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13(14):4042\u20134045. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2316","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1750_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","volume":"55","author":"T Kim","year":"2023","unstructured":"Kim T, Croce CM (2023) MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Exp Mol Med 55(7):1314\u20131321. https:\/\/doi.org\/10.1038\/s12276-023-01050-9","journal-title":"Exp Mol Med"},{"issue":"5","key":"1750_CR30","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8(5):387\u2013398. https:\/\/doi.org\/10.1038\/nrc2389","journal-title":"Nat Rev Cancer"},{"key":"1750_CR31","doi-asserted-by":"publisher","unstructured":"Korotkevich G et al (2016) Fast gene set enrichment analysis. https:\/\/doi.org\/10.1101\/060012","DOI":"10.1101\/060012"},{"issue":"4","key":"1750_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/OP.22.00476","volume":"19","author":"R Kotecha","year":"2023","unstructured":"Kotecha R et al (2023) Key clinical principles in the management of glioblastoma. JCO Oncol Pract 19(4):180\u2013189. https:\/\/doi.org\/10.1200\/OP.22.00476","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"1750_CR33","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/molecules14041561","volume":"14","author":"GV Koukourakis","year":"2009","unstructured":"Koukourakis GV et al (2009) Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article. molecules 14(4):1561\u20131577. https:\/\/doi.org\/10.3390\/molecules14041561","journal-title":"Molecules"},{"issue":"6","key":"1750_CR34","first-page":"1309","volume":"146","author":"S Krajewski","year":"1995","unstructured":"Krajewski S et al (1995) Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146(6):1309\u20131319","journal-title":"Am J Pathol"},{"issue":"6","key":"1750_CR35","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/hep.22256","volume":"47","author":"Y Ladeiro","year":"2008","unstructured":"Ladeiro Y et al (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations. Hepatology 47(6):1955\u20131963. https:\/\/doi.org\/10.1002\/hep.22256","journal-title":"Hepatology"},{"key":"1750_CR36","doi-asserted-by":"publisher","unstructured":"Li M et al (2023) Potassium channels: Novel targets for tumor diagnosis and chemoresistance. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.1074469","DOI":"10.3389\/fonc.2022.1074469"},{"issue":"3","key":"1750_CR37","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1074-7613(03)00234-6","volume":"19","author":"X Liu","year":"2003","unstructured":"Liu X et al (2003) The structure of a Bcl-xL\/Bim fragment complex. Immunity 19(3):341\u2013352. https:\/\/doi.org\/10.1016\/S1074-7613(03)00234-6","journal-title":"Immunity"},{"issue":"5","key":"1750_CR38","doi-asserted-by":"publisher","first-page":"7527","DOI":"10.1002\/jcb.28027","volume":"120","author":"L Ma","year":"2019","unstructured":"Ma L et al (2019) miR-129\u20105p and \u20103p co\u2010target WWP1 to suppress gastric cancer proliferation and migration. J Cell Biochem 120(5):7527\u20137538. https:\/\/doi.org\/10.1002\/jcb.28027","journal-title":"J Cell Biochem"},{"issue":"1","key":"1750_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/1471-2407-11-327","volume":"11","author":"H Mattila","year":"2011","unstructured":"Mattila H et al (2011) NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene. BMC Cancer 11(1):327. https:\/\/doi.org\/10.1186\/1471-2407-11-327","journal-title":"BMC Cancer"},{"key":"1750_CR40","unstructured":"MethylDackel (n.d.). https:\/\/github.com\/dpryan79\/MethylDackel"},{"issue":"3","key":"1750_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/wsbm.1331","volume":"8","author":"S Mitchell","year":"2016","unstructured":"Mitchell S, Vargas J, Hoffmann A (2016) Signaling via the NF\u03baB system. Wiley Interdiscip Rev Syst Biol Med 8(3):227\u2013241. https:\/\/doi.org\/10.1002\/wsbm.1331","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"9","key":"1750_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","volume":"5","author":"RT Moon","year":"2004","unstructured":"Moon RT et al (2004) WNT and \u03b2-catenin signalling: diseases and therapies. Nat Rev Genet 5(9):691\u2013701. https:\/\/doi.org\/10.1038\/nrg1427","journal-title":"Nat Rev Genet"},{"issue":"4","key":"1750_CR43","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel C et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178(4):835\u2013849. https:\/\/doi.org\/10.1016\/j.cell.2019.06.024. .e21","journal-title":"Cell"},{"issue":"3","key":"1750_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/tpj.13866","volume":"94","author":"N Ogita","year":"2018","unstructured":"Ogita N et al (2018) Identifying the target genes of SUPPRESSOR OF GAMMA RESPONSE\u20091, a master transcription factor controlling\u2009 DNA damage response in Arabidopsis. Plant J 94(3):439\u2013453. https:\/\/doi.org\/10.1111\/tpj.13866","journal-title":"Plant J"},{"issue":"12","key":"1750_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11910-021-01152-9","volume":"21","author":"QT Ostrom","year":"2021","unstructured":"Ostrom QT, Francis SS, Barnholtz-Sloan JS (2021) Epidemiology of brain and other CNS tumors. Curr Neurol Neurosci Rep 21(12):68. https:\/\/doi.org\/10.1007\/s11910-021-01152-9","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6190","key":"1750_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel AP et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396\u20131401. https:\/\/doi.org\/10.1126\/science.1254257","journal-title":"Science"},{"key":"1750_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.565950","author":"DA Patten","year":"2020","unstructured":"Patten DA et al (2020) Prognostic value and potential immunoregulatory role of SCARF1 in hepatocellular carcinoma. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.565950","journal-title":"Front Oncol"},{"key":"1750_CR48","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7583","author":"G Peng","year":"2019","unstructured":"Peng G et al (2019) miR\u201325\u20133p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3. Exp Therap Med. https:\/\/doi.org\/10.3892\/etm.2019.7583","journal-title":"Experimental Therapeutic Med"},{"key":"1750_CR49","unstructured":"Press release. NobelPrize.org. Nobel Prize Outreach 2025. (n.d.). https:\/\/www.nobelprize.org\/prizes\/medicine\/2024\/press-release\/. Accessed 12 Aug 2025"},{"key":"1750_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.815646","author":"MC Proto","year":"2022","unstructured":"Proto MC et al (2022) Modified adenosines sensitize glioblastoma cells to temozolomide by affecting DNA methyltransferases. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.815646","journal-title":"Front Pharmacol"},{"issue":"7035","key":"1750_CR51","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434(7035):843\u2013850. https:\/\/doi.org\/10.1038\/nature03319","journal-title":"Nature"},{"key":"1750_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05006-1","author":"C Riess","year":"2022","unstructured":"Riess C et al (2022) Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-022-05006-1","journal-title":"Cell Death Dis"},{"issue":"20","key":"1750_CR53","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1111\/febs.16136","volume":"289","author":"M Sancho","year":"2022","unstructured":"Sancho M et al (2022) Understanding MCL1: from cellular function and regulation to pharmacological inhibition. FEBS J 289(20):6209\u20136234. https:\/\/doi.org\/10.1111\/febs.16136","journal-title":"FEBS J"},{"issue":"6","key":"1750_CR54","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/ijc.24522","volume":"125","author":"T Sasayama","year":"2009","unstructured":"Sasayama T et al (2009) MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer 125(6):1407\u20131413. https:\/\/doi.org\/10.1002\/ijc.24522","journal-title":"Int J Cancer"},{"issue":"3","key":"1750_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40265-020-01269-0","volume":"80","author":"LJ Scott","year":"2020","unstructured":"Scott LJ (2020) Givosiran: first approval. Drugs 80(3):335\u2013339. https:\/\/doi.org\/10.1007\/s40265-020-01269-0","journal-title":"Drugs"},{"issue":"2","key":"1750_CR56","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40265-020-01463-0","volume":"81","author":"LJ Scott","year":"2021","unstructured":"Scott LJ, Keam SJ (2021) Lumasiran: first approval. Drugs 81(2):277\u2013282. https:\/\/doi.org\/10.1007\/s40265-020-01463-0","journal-title":"Drugs"},{"key":"1750_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1662","author":"LF Sempere","year":"2021","unstructured":"Sempere LF, Azmi AS, Moore A (2021) microRNA-based diagnostic and therapeutic applications in cancer medicine. WIREs RNA. https:\/\/doi.org\/10.1002\/wrna.1662","journal-title":"WIREs RNA"},{"issue":"17","key":"1750_CR58","doi-asserted-by":"publisher","first-page":"13085","DOI":"10.3390\/ijms241713085","volume":"24","author":"F Sep\u00falveda","year":"2023","unstructured":"Sep\u00falveda F et al (2023) EV-miRNA-mediated intercellular communication in the breast tumor microenvironment. Int J Mol Sci 24(17):13085. https:\/\/doi.org\/10.3390\/ijms241713085","journal-title":"Int J Mol Sci"},{"key":"1750_CR59","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.79","author":"N Singh","year":"2020","unstructured":"Singh N et al (2020) Mechanisms of temozolomide resistance in glioblastoma\u2014a comprehensive review. Cancer Drug Resist. https:\/\/doi.org\/10.20517\/cdr.2020.79","journal-title":"Cancer Drug Resist"},{"issue":"9","key":"1750_CR60","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1470-2045(01)00489-2","volume":"2","author":"R Stupp","year":"2001","unstructured":"Stupp R et al (2001) Current and future developments in the use of temozolomide for the treatment of brain tumours. Lancet Oncol 2(9):552\u2013560. https:\/\/doi.org\/10.1016\/S1470-2045(01)00489-2","journal-title":"Lancet Oncol"},{"issue":"10","key":"1750_CR61","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"23","key":"1750_CR62","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma. JAMA 318(23):2306. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"issue":"44","key":"1750_CR63","doi-asserted-by":"publisher","first-page":"30257","DOI":"10.1074\/jbc.M114.583419","volume":"289","author":"J Suzuki","year":"2014","unstructured":"Suzuki J, Imanishi E, Nagata S (2014) Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. J Biol Chem 289(44):30257\u201330267. https:\/\/doi.org\/10.1074\/jbc.M114.583419","journal-title":"J Biol Chem"},{"issue":"4","key":"1750_CR64","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC et al (2020) Management of glioblastoma: state of the art and future directions. Cancer J Clin 70(4):299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613","journal-title":"Cancer J Clin"},{"issue":"10","key":"1750_CR65","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41587-022-01336-9","volume":"40","author":"M Tani\u0107","year":"2022","unstructured":"Tani\u0107 M et al (2022) Comparison and imputation-aided integration of five commercial platforms for targeted DNA methylome analysis. Nat Biotechnol 40(10):1478\u20131487. https:\/\/doi.org\/10.1038\/s41587-022-01336-9","journal-title":"Nat Biotechnol"},{"key":"1750_CR66","doi-asserted-by":"publisher","unstructured":"Tian X et al (2024) Targeting apoptotic pathways for cancer therapy. J Clin Invest 134(14). https:\/\/doi.org\/10.1172\/JCI179570","DOI":"10.1172\/JCI179570"},{"issue":"8","key":"1750_CR67","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/ijc.27746","volume":"132","author":"K Ueno","year":"2013","unstructured":"Ueno K et al (2013) Frizzled homolog proteins, microRNAs and Wnt signaling in cancer. Int J Cancer 132(8):1731\u20131740. https:\/\/doi.org\/10.1002\/ijc.27746","journal-title":"Int J Cancer"},{"issue":"2","key":"1750_CR68","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/ijo.2021.5244","volume":"59","author":"J Wang","year":"2021","unstructured":"Wang J, Li T, Wang B (2021) Exosomal transfer of miR\u201325\u20133p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7. Int J Oncol 59(2):64. https:\/\/doi.org\/10.3892\/ijo.2021.5244","journal-title":"Int J Oncol"},{"issue":"5","key":"1750_CR69","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1007\/S10528-024-10895-2","volume":"63","author":"M Wang","year":"2025","unstructured":"Wang M et al (2025) Downregulation of RNF128 Inhibits the proliferation, migration, invasion and EMT of colorectal cancer cells. Biochem Genet 63(5):3796\u20133807. https:\/\/doi.org\/10.1007\/S10528-024-10895-2","journal-title":"Biochem Genet"},{"issue":"22","key":"1750_CR70","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3748\/wjg.v18.i22.2745","volume":"18","author":"H Yamamoto","year":"2012","unstructured":"Yamamoto H (2012) Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. World J Gastroenterol 18(22):2745. https:\/\/doi.org\/10.3748\/wjg.v18.i22.2745","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1750_CR71","doi-asserted-by":"publisher","first-page":"e0178908","DOI":"10.1371\/journal.pone.0178908","volume":"12","author":"D Yang","year":"2017","unstructured":"Yang D et al (2017) Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling. PLoS ONE 12(6):e0178908. https:\/\/doi.org\/10.1371\/journal.pone.0178908","journal-title":"PLoS ONE"},{"issue":"6","key":"1750_CR72","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/LIV.14803","volume":"41","author":"Y Yi","year":"2021","unstructured":"Yi Y et al (2021) MNS1 promotes hepatocarcinogenesis and metastasis via activating PI3K\/AKT by translocating \u03b2-catenin and predicts poor prognosis. Liver Int: Off J Int Assoc Study Liver 41(6):1409\u20131420. https:\/\/doi.org\/10.1111\/LIV.14803","journal-title":"Liver international: official J Int Association Study Liver"},{"issue":"9","key":"1750_CR73","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41419-020-02988-8","volume":"11","author":"E-J Yun","year":"2020","unstructured":"Yun E-J et al (2020) Wnt\/\u03b2-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma. Cell Death Dis 11(9):771. https:\/\/doi.org\/10.1038\/s41419-020-02988-8","journal-title":"Cell Death Dis"},{"issue":"1","key":"1750_CR74","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1038\/s41467-018-07810-w","volume":"9","author":"Z Zeng","year":"2018","unstructured":"Zeng Z et al (2018) Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun 9(1):5395. https:\/\/doi.org\/10.1038\/s41467-018-07810-w","journal-title":"Nat Commun"},{"issue":"11","key":"1750_CR75","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461\u20131473. https:\/\/doi.org\/10.1038\/onc.2016.304","journal-title":"Oncogene"},{"issue":"1","key":"1750_CR77","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41467-019-09712-x","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J et al (2019) Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Nat Commun 10(1):1858. https:\/\/doi.org\/10.1038\/s41467-019-09712-x","journal-title":"Nat Commun"},{"key":"1750_CR78","doi-asserted-by":"publisher","first-page":"114432","DOI":"10.1016\/j.bcp.2021.114432","volume":"189","author":"MM Zhang","year":"2021","unstructured":"Zhang MM et al (2021) The growth of siRNA-based therapeutics: updated clinical studies. Biochem Pharmacol 189:114432. https:\/\/doi.org\/10.1016\/j.bcp.2021.114432","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"1750_CR76","doi-asserted-by":"publisher","first-page":"11389","DOI":"10.3390\/ijms231911389","volume":"23","author":"C Zhang","year":"2022","unstructured":"Zhang C et al (2022) Overview of MicroRNAs as diagnostic and prognostic biomarkers for high-incidence cancers in 2021. Int J Mol Sci 23(19):11389. https:\/\/doi.org\/10.3390\/ijms231911389","journal-title":"Int J Mol Sci"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01750-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01750-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T18:38:15Z","timestamp":1780166295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01750-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01750-6","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no financial or non-financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were approved by the Ethics Committee of the Rostock University Medical Center, University of Rostock (Ethikkommission an der Medizinischen Fakult\u00e4t der Universit\u00e4t Rostock, St.-Georg-Str. 108, 18055 Rostock, Germany; Ethics Registration ID: A2018-0167) in accordance with generally accepted guidelines for the use of human material.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All cell lines used in this study were originally established from tumor tissue with informed written patient consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"97"}}